Iron Deficiency Anemia
Iron Deficiency Anemia - Related Videos
08:45
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
0 Views •
Cited by 3 •
2022
This article demonstrates how to prepare and administer transferrin-bound nonradioactive isotopic iron for studies of iron transport in mouse pregnancy. The approach for quantifying isotopic iron in fetoplacental compartments is also described.
03:06
Culturing Mycobacterium tuberculosis Under Iron-Limited Conditions
0 Views •
2025
Source: Gupta, S., et al. Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria. J. Vis. Exp. (2019)This video demonstrates the procedure for culturing Mycobacterium tuberculosis under iron-limited conditions to induce iron stress and promote the secretion of siderophores that support bacterial survival.
06:37
Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
0 Views •
Cited by 31 •
2013
Here we describe a growth assay for Staphylococcus aureus using hemoglobin as the sole source of available nutrient iron. This assay establishes the role of bacterial factors involved in hemoglobin-derived iron acquisition.
01:25
Capital Deficiency in Liquidation: II
0 Views •
2026
A capital deficiency occurs when a partner's capital account has a debit balance during partnership liquidation. It may result from operating losses, excessive drawings, or losses from the sale of partnership assets. During liquidation, noncash assets are sold, liabilities are paid, gains or losses are allocated to the partners, and the remaining cash is distributed based on the partners' capital balances.Example: Ace Company decides to liquidate because it is nearing bankruptcy. Noncash assets...
01:30
No Capital Deficiency in Liquidation
0 Views •
2026
In accounting, liquidation without capital deficiency is a structured process that enables a partnership to dissolve equitably when partners possess sufficient capital to cover all liabilities and allocated losses. This condition ensures that no partner is required to contribute additional funds to the partnership, streamlining the dissolution procedure.The liquidation process begins with conversion of noncash assets into cash. When these assets are sold, any difference between the sale price...
FAQs
Iron is required for heme synthesis, the part of hemoglobin that enables red blood cells to transport oxygen. When iron stores fall, cells produce less hemoglobin during development. The resulting red blood cells become smaller and paler than typical cells, providing a visible connection between impaired iron availability, altered cell structure, and reduced oxygen delivery.
Several biological pathways can reduce available iron. Insufficient intake limits the amount entering the body, while poor absorption restricts its uptake. Physiological demand can exceed supply during periods of increased need, and chronic blood loss can progressively deplete existing stores. Distinguishing these pathways helps connect the blood disorder with nutrition, digestion, physiology, or ongoing loss.
Iron stores provide a reserve that supports continued heme and hemoglobin synthesis when immediate intake does not fully meet cellular needs. As those reserves decline, the body has less available iron for red blood cell production. This relationship makes iron status relevant alongside hemoglobin measurements when evaluating the biological progression of deficiency.
Laboratory evaluation considers hemoglobin, red blood cell indices, and measures of iron status. Hemoglobin indicates the blood’s oxygen-carrying capacity, while red blood cell indices help identify changes in cell size and color. Iron-status measurements add information about available or stored iron, allowing the findings to be interpreted as a connected pattern.
The combination of hemoglobin results, red blood cell indices, and iron-status information supports diagnosis and treatment planning. Using several types of measurements is more informative than relying on a single value because the tests address oxygen-carrying capacity, cellular characteristics, and iron availability. These findings also help inform strategies intended to prevent recurrence or worsening.
This condition provides a model for examining how nutrition, metabolism, blood-cell production, and oxygen transport interact. Its causes also create public health questions about adequate intake, physiological demand, absorption, and chronic blood loss. Consequently, research can connect laboratory findings with prevention strategies designed for populations at risk, not only with individual diagnosis.